December 10, 2024
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables
October 22, 2024
Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China
July 10, 2024
Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites with Better Than Expected Results
February 20, 2024
Leading Cervical Cancer Doctors Support Approval of LuViva in China Based on Preliminary Review of Clinical Trial Results